Global Personalized Medicine for Cancer Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Personalized Medicine for Cancer market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Personalized Medicine for Cancer industry chain, the market status of Breast Cancer (Immunotherapy, Targeted Therapy), Blood Cancer (Immunotherapy, Targeted Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Personalized Medicine for Cancer.

Regionally, the report analyzes the Personalized Medicine for Cancer markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Personalized Medicine for Cancer market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Personalized Medicine for Cancer market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Personalized Medicine for Cancer industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunotherapy, Targeted Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Personalized Medicine for Cancer market.

Regional Analysis: The report involves examining the Personalized Medicine for Cancer market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Personalized Medicine for Cancer market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Personalized Medicine for Cancer:
Company Analysis: Report covers individual Personalized Medicine for Cancer players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Personalized Medicine for Cancer This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Breast Cancer, Blood Cancer).

Technology Analysis: Report covers specific technologies relevant to Personalized Medicine for Cancer. It assesses the current state, advancements, and potential future developments in Personalized Medicine for Cancer areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Personalized Medicine for Cancer market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Personalized Medicine for Cancer market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Immunotherapy
    Targeted Therapy
    Chemotherapy
    Hormone Therapy
    Others

Market segment by Application
    Breast Cancer
    Blood Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Skin Cancer
    Lung Cancer
    Others

Market segment by players, this report covers
    Bayer
    GlaxoSmithKline
    Novartis
    Sanofi
    Pfizer
    Amgen
    Merck
    Bristol-Myers Squibb
    Ariad Pharmaceuticals (Takeda)
    Eli Lilly
    Roche
    Boehringer Ingelheim
    Johnson and Johnson
    Teva Pharmaceuticals

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Personalized Medicine for Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Medicine for Cancer, with revenue, gross margin and global market share of Personalized Medicine for Cancer from 2019 to 2024.
Chapter 3, the Personalized Medicine for Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Personalized Medicine for Cancer market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Medicine for Cancer.
Chapter 13, to describe Personalized Medicine for Cancer research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Personalized Medicine for Cancer
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Personalized Medicine for Cancer by Type
        1.3.1 Overview: Global Personalized Medicine for Cancer Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Personalized Medicine for Cancer Consumption Value Market Share by Type in 2023
        1.3.3 Immunotherapy
        1.3.4 Targeted Therapy
        1.3.5 Chemotherapy
        1.3.6 Hormone Therapy
        1.3.7 Others
    1.4 Global Personalized Medicine for Cancer Market by Application
        1.4.1 Overview: Global Personalized Medicine for Cancer Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Breast Cancer
        1.4.3 Blood Cancer
        1.4.4 Gastrointestinal Cancer
        1.4.5 Prostate Cancer
        1.4.6 Skin Cancer
        1.4.7 Lung Cancer
        1.4.8 Others
    1.5 Global Personalized Medicine for Cancer Market Size & Forecast
    1.6 Global Personalized Medicine for Cancer Market Size and Forecast by Region
        1.6.1 Global Personalized Medicine for Cancer Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Personalized Medicine for Cancer Market Size by Region, (2019-2030)
        1.6.3 North America Personalized Medicine for Cancer Market Size and Prospect (2019-2030)
        1.6.4 Europe Personalized Medicine for Cancer Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Personalized Medicine for Cancer Market Size and Prospect (2019-2030)
        1.6.6 South America Personalized Medicine for Cancer Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Personalized Medicine for Cancer Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Personalized Medicine for Cancer Product and Solutions
        2.1.4 Bayer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bayer Recent Developments and Future Plans
    2.2 GlaxoSmithKline
        2.2.1 GlaxoSmithKline Details
        2.2.2 GlaxoSmithKline Major Business
        2.2.3 GlaxoSmithKline Personalized Medicine for Cancer Product and Solutions
        2.2.4 GlaxoSmithKline Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 GlaxoSmithKline Recent Developments and Future Plans
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Personalized Medicine for Cancer Product and Solutions
        2.3.4 Novartis Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Novartis Recent Developments and Future Plans
    2.4 Sanofi
        2.4.1 Sanofi Details
        2.4.2 Sanofi Major Business
        2.4.3 Sanofi Personalized Medicine for Cancer Product and Solutions
        2.4.4 Sanofi Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Sanofi Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer Personalized Medicine for Cancer Product and Solutions
        2.5.4 Pfizer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Amgen
        2.6.1 Amgen Details
        2.6.2 Amgen Major Business
        2.6.3 Amgen Personalized Medicine for Cancer Product and Solutions
        2.6.4 Amgen Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Amgen Recent Developments and Future Plans
    2.7 Merck
        2.7.1 Merck Details
        2.7.2 Merck Major Business
        2.7.3 Merck Personalized Medicine for Cancer Product and Solutions
        2.7.4 Merck Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Merck Recent Developments and Future Plans
    2.8 Bristol-Myers Squibb
        2.8.1 Bristol-Myers Squibb Details
        2.8.2 Bristol-Myers Squibb Major Business
        2.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Product and Solutions
        2.8.4 Bristol-Myers Squibb Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.9 Ariad Pharmaceuticals (Takeda)
        2.9.1 Ariad Pharmaceuticals (Takeda) Details
        2.9.2 Ariad Pharmaceuticals (Takeda) Major Business
        2.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product and Solutions
        2.9.4 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Ariad Pharmaceuticals (Takeda) Recent Developments and Future Plans
    2.10 Eli Lilly
        2.10.1 Eli Lilly Details
        2.10.2 Eli Lilly Major Business
        2.10.3 Eli Lilly Personalized Medicine for Cancer Product and Solutions
        2.10.4 Eli Lilly Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Eli Lilly Recent Developments and Future Plans
    2.11 Roche
        2.11.1 Roche Details
        2.11.2 Roche Major Business
        2.11.3 Roche Personalized Medicine for Cancer Product and Solutions
        2.11.4 Roche Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Roche Recent Developments and Future Plans
    2.12 Boehringer Ingelheim
        2.12.1 Boehringer Ingelheim Details
        2.12.2 Boehringer Ingelheim Major Business
        2.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Product and Solutions
        2.12.4 Boehringer Ingelheim Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.13 Johnson and Johnson
        2.13.1 Johnson and Johnson Details
        2.13.2 Johnson and Johnson Major Business
        2.13.3 Johnson and Johnson Personalized Medicine for Cancer Product and Solutions
        2.13.4 Johnson and Johnson Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Johnson and Johnson Recent Developments and Future Plans
    2.14 Teva Pharmaceuticals
        2.14.1 Teva Pharmaceuticals Details
        2.14.2 Teva Pharmaceuticals Major Business
        2.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Product and Solutions
        2.14.4 Teva Pharmaceuticals Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Teva Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Personalized Medicine for Cancer Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Personalized Medicine for Cancer by Company Revenue
        3.2.2 Top 3 Personalized Medicine for Cancer Players Market Share in 2023
        3.2.3 Top 6 Personalized Medicine for Cancer Players Market Share in 2023
    3.3 Personalized Medicine for Cancer Market: Overall Company Footprint Analysis
        3.3.1 Personalized Medicine for Cancer Market: Region Footprint
        3.3.2 Personalized Medicine for Cancer Market: Company Product Type Footprint
        3.3.3 Personalized Medicine for Cancer Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Personalized Medicine for Cancer Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Personalized Medicine for Cancer Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Personalized Medicine for Cancer Consumption Value Market Share by Application (2019-2024)
    5.2 Global Personalized Medicine for Cancer Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Personalized Medicine for Cancer Consumption Value by Type (2019-2030)
    6.2 North America Personalized Medicine for Cancer Consumption Value by Application (2019-2030)
    6.3 North America Personalized Medicine for Cancer Market Size by Country
        6.3.1 North America Personalized Medicine for Cancer Consumption Value by Country (2019-2030)
        6.3.2 United States Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        6.3.3 Canada Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        6.3.4 Mexico Personalized Medicine for Cancer Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Personalized Medicine for Cancer Consumption Value by Type (2019-2030)
    7.2 Europe Personalized Medicine for Cancer Consumption Value by Application (2019-2030)
    7.3 Europe Personalized Medicine for Cancer Market Size by Country
        7.3.1 Europe Personalized Medicine for Cancer Consumption Value by Country (2019-2030)
        7.3.2 Germany Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        7.3.3 France Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        7.3.5 Russia Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        7.3.6 Italy Personalized Medicine for Cancer Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Personalized Medicine for Cancer Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Personalized Medicine for Cancer Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Personalized Medicine for Cancer Market Size by Region
        8.3.1 Asia-Pacific Personalized Medicine for Cancer Consumption Value by Region (2019-2030)
        8.3.2 China Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        8.3.3 Japan Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        8.3.4 South Korea Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        8.3.5 India Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        8.3.7 Australia Personalized Medicine for Cancer Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Personalized Medicine for Cancer Consumption Value by Type (2019-2030)
    9.2 South America Personalized Medicine for Cancer Consumption Value by Application (2019-2030)
    9.3 South America Personalized Medicine for Cancer Market Size by Country
        9.3.1 South America Personalized Medicine for Cancer Consumption Value by Country (2019-2030)
        9.3.2 Brazil Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        9.3.3 Argentina Personalized Medicine for Cancer Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Personalized Medicine for Cancer Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Personalized Medicine for Cancer Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Personalized Medicine for Cancer Market Size by Country
        10.3.1 Middle East & Africa Personalized Medicine for Cancer Consumption Value by Country (2019-2030)
        10.3.2 Turkey Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Personalized Medicine for Cancer Market Size and Forecast (2019-2030)
        10.3.4 UAE Personalized Medicine for Cancer Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Personalized Medicine for Cancer Market Drivers
    11.2 Personalized Medicine for Cancer Market Restraints
    11.3 Personalized Medicine for Cancer Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Personalized Medicine for Cancer Industry Chain
    12.2 Personalized Medicine for Cancer Upstream Analysis
    12.3 Personalized Medicine for Cancer Midstream Analysis
    12.4 Personalized Medicine for Cancer Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Personalized Medicine for Cancer Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Personalized Medicine for Cancer Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Personalized Medicine for Cancer Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Personalized Medicine for Cancer Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Bayer Company Information, Head Office, and Major Competitors
    Table 6. Bayer Major Business
    Table 7. Bayer Personalized Medicine for Cancer Product and Solutions
    Table 8. Bayer Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Bayer Recent Developments and Future Plans
    Table 10. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 11. GlaxoSmithKline Major Business
    Table 12. GlaxoSmithKline Personalized Medicine for Cancer Product and Solutions
    Table 13. GlaxoSmithKline Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. GlaxoSmithKline Recent Developments and Future Plans
    Table 15. Novartis Company Information, Head Office, and Major Competitors
    Table 16. Novartis Major Business
    Table 17. Novartis Personalized Medicine for Cancer Product and Solutions
    Table 18. Novartis Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Novartis Recent Developments and Future Plans
    Table 20. Sanofi Company Information, Head Office, and Major Competitors
    Table 21. Sanofi Major Business
    Table 22. Sanofi Personalized Medicine for Cancer Product and Solutions
    Table 23. Sanofi Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Sanofi Recent Developments and Future Plans
    Table 25. Pfizer Company Information, Head Office, and Major Competitors
    Table 26. Pfizer Major Business
    Table 27. Pfizer Personalized Medicine for Cancer Product and Solutions
    Table 28. Pfizer Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Pfizer Recent Developments and Future Plans
    Table 30. Amgen Company Information, Head Office, and Major Competitors
    Table 31. Amgen Major Business
    Table 32. Amgen Personalized Medicine for Cancer Product and Solutions
    Table 33. Amgen Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Amgen Recent Developments and Future Plans
    Table 35. Merck Company Information, Head Office, and Major Competitors
    Table 36. Merck Major Business
    Table 37. Merck Personalized Medicine for Cancer Product and Solutions
    Table 38. Merck Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Merck Recent Developments and Future Plans
    Table 40. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
    Table 41. Bristol-Myers Squibb Major Business
    Table 42. Bristol-Myers Squibb Personalized Medicine for Cancer Product and Solutions
    Table 43. Bristol-Myers Squibb Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Bristol-Myers Squibb Recent Developments and Future Plans
    Table 45. Ariad Pharmaceuticals (Takeda) Company Information, Head Office, and Major Competitors
    Table 46. Ariad Pharmaceuticals (Takeda) Major Business
    Table 47. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product and Solutions
    Table 48. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Ariad Pharmaceuticals (Takeda) Recent Developments and Future Plans
    Table 50. Eli Lilly Company Information, Head Office, and Major Competitors
    Table 51. Eli Lilly Major Business
    Table 52. Eli Lilly Personalized Medicine for Cancer Product and Solutions
    Table 53. Eli Lilly Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Eli Lilly Recent Developments and Future Plans
    Table 55. Roche Company Information, Head Office, and Major Competitors
    Table 56. Roche Major Business
    Table 57. Roche Personalized Medicine for Cancer Product and Solutions
    Table 58. Roche Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Roche Recent Developments and Future Plans
    Table 60. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
    Table 61. Boehringer Ingelheim Major Business
    Table 62. Boehringer Ingelheim Personalized Medicine for Cancer Product and Solutions
    Table 63. Boehringer Ingelheim Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Boehringer Ingelheim Recent Developments and Future Plans
    Table 65. Johnson and Johnson Company Information, Head Office, and Major Competitors
    Table 66. Johnson and Johnson Major Business
    Table 67. Johnson and Johnson Personalized Medicine for Cancer Product and Solutions
    Table 68. Johnson and Johnson Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Johnson and Johnson Recent Developments and Future Plans
    Table 70. Teva Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 71. Teva Pharmaceuticals Major Business
    Table 72. Teva Pharmaceuticals Personalized Medicine for Cancer Product and Solutions
    Table 73. Teva Pharmaceuticals Personalized Medicine for Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Teva Pharmaceuticals Recent Developments and Future Plans
    Table 75. Global Personalized Medicine for Cancer Revenue (USD Million) by Players (2019-2024)
    Table 76. Global Personalized Medicine for Cancer Revenue Share by Players (2019-2024)
    Table 77. Breakdown of Personalized Medicine for Cancer by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Personalized Medicine for Cancer, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 79. Head Office of Key Personalized Medicine for Cancer Players
    Table 80. Personalized Medicine for Cancer Market: Company Product Type Footprint
    Table 81. Personalized Medicine for Cancer Market: Company Product Application Footprint
    Table 82. Personalized Medicine for Cancer New Market Entrants and Barriers to Market Entry
    Table 83. Personalized Medicine for Cancer Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Personalized Medicine for Cancer Consumption Value (USD Million) by Type (2019-2024)
    Table 85. Global Personalized Medicine for Cancer Consumption Value Share by Type (2019-2024)
    Table 86. Global Personalized Medicine for Cancer Consumption Value Forecast by Type (2025-2030)
    Table 87. Global Personalized Medicine for Cancer Consumption Value by Application (2019-2024)
    Table 88. Global Personalized Medicine for Cancer Consumption Value Forecast by Application (2025-2030)
    Table 89. North America Personalized Medicine for Cancer Consumption Value by Type (2019-2024) & (USD Million)
    Table 90. North America Personalized Medicine for Cancer Consumption Value by Type (2025-2030) & (USD Million)
    Table 91. North America Personalized Medicine for Cancer Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. North America Personalized Medicine for Cancer Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. North America Personalized Medicine for Cancer Consumption Value by Country (2019-2024) & (USD Million)
    Table 94. North America Personalized Medicine for Cancer Consumption Value by Country (2025-2030) & (USD Million)
    Table 95. Europe Personalized Medicine for Cancer Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Europe Personalized Medicine for Cancer Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Europe Personalized Medicine for Cancer Consumption Value by Application (2019-2024) & (USD Million)
    Table 98. Europe Personalized Medicine for Cancer Consumption Value by Application (2025-2030) & (USD Million)
    Table 99. Europe Personalized Medicine for Cancer Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Personalized Medicine for Cancer Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Personalized Medicine for Cancer Consumption Value by Type (2019-2024) & (USD Million)
    Table 102. Asia-Pacific Personalized Medicine for Cancer Consumption Value by Type (2025-2030) & (USD Million)
    Table 103. Asia-Pacific Personalized Medicine for Cancer Consumption Value by Application (2019-2024) & (USD Million)
    Table 104. Asia-Pacific Personalized Medicine for Cancer Consumption Value by Application (2025-2030) & (USD Million)
    Table 105. Asia-Pacific Personalized Medicine for Cancer Consumption Value by Region (2019-2024) & (USD Million)
    Table 106. Asia-Pacific Personalized Medicine for Cancer Consumption Value by Region (2025-2030) & (USD Million)
    Table 107. South America Personalized Medicine for Cancer Consumption Value by Type (2019-2024) & (USD Million)
    Table 108. South America Personalized Medicine for Cancer Consumption Value by Type (2025-2030) & (USD Million)
    Table 109. South America Personalized Medicine for Cancer Consumption Value by Application (2019-2024) & (USD Million)
    Table 110. South America Personalized Medicine for Cancer Consumption Value by Application (2025-2030) & (USD Million)
    Table 111. South America Personalized Medicine for Cancer Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. South America Personalized Medicine for Cancer Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Middle East & Africa Personalized Medicine for Cancer Consumption Value by Type (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Personalized Medicine for Cancer Consumption Value by Type (2025-2030) & (USD Million)
    Table 115. Middle East & Africa Personalized Medicine for Cancer Consumption Value by Application (2019-2024) & (USD Million)
    Table 116. Middle East & Africa Personalized Medicine for Cancer Consumption Value by Application (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Personalized Medicine for Cancer Consumption Value by Country (2019-2024) & (USD Million)
    Table 118. Middle East & Africa Personalized Medicine for Cancer Consumption Value by Country (2025-2030) & (USD Million)
    Table 119. Personalized Medicine for Cancer Raw Material
    Table 120. Key Suppliers of Personalized Medicine for Cancer Raw Materials
List of Figures
    Figure 1. Personalized Medicine for Cancer Picture
    Figure 2. Global Personalized Medicine for Cancer Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Personalized Medicine for Cancer Consumption Value Market Share by Type in 2023
    Figure 4. Immunotherapy
    Figure 5. Targeted Therapy
    Figure 6. Chemotherapy
    Figure 7. Hormone Therapy
    Figure 8. Others
    Figure 9. Global Personalized Medicine for Cancer Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 10. Personalized Medicine for Cancer Consumption Value Market Share by Application in 2023
    Figure 11. Breast Cancer Picture
    Figure 12. Blood Cancer Picture
    Figure 13. Gastrointestinal Cancer Picture
    Figure 14. Prostate Cancer Picture
    Figure 15. Skin Cancer Picture
    Figure 16. Lung Cancer Picture
    Figure 17. Others Picture
    Figure 18. Global Personalized Medicine for Cancer Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 19. Global Personalized Medicine for Cancer Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 20. Global Market Personalized Medicine for Cancer Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 21. Global Personalized Medicine for Cancer Consumption Value Market Share by Region (2019-2030)
    Figure 22. Global Personalized Medicine for Cancer Consumption Value Market Share by Region in 2023
    Figure 23. North America Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 24. Europe Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 25. Asia-Pacific Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 26. South America Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 27. Middle East and Africa Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 28. Global Personalized Medicine for Cancer Revenue Share by Players in 2023
    Figure 29. Personalized Medicine for Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 30. Global Top 3 Players Personalized Medicine for Cancer Market Share in 2023
    Figure 31. Global Top 6 Players Personalized Medicine for Cancer Market Share in 2023
    Figure 32. Global Personalized Medicine for Cancer Consumption Value Share by Type (2019-2024)
    Figure 33. Global Personalized Medicine for Cancer Market Share Forecast by Type (2025-2030)
    Figure 34. Global Personalized Medicine for Cancer Consumption Value Share by Application (2019-2024)
    Figure 35. Global Personalized Medicine for Cancer Market Share Forecast by Application (2025-2030)
    Figure 36. North America Personalized Medicine for Cancer Consumption Value Market Share by Type (2019-2030)
    Figure 37. North America Personalized Medicine for Cancer Consumption Value Market Share by Application (2019-2030)
    Figure 38. North America Personalized Medicine for Cancer Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 40. Canada Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 41. Mexico Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 42. Europe Personalized Medicine for Cancer Consumption Value Market Share by Type (2019-2030)
    Figure 43. Europe Personalized Medicine for Cancer Consumption Value Market Share by Application (2019-2030)
    Figure 44. Europe Personalized Medicine for Cancer Consumption Value Market Share by Country (2019-2030)
    Figure 45. Germany Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 46. France Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 47. United Kingdom Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 48. Russia Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 49. Italy Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 50. Asia-Pacific Personalized Medicine for Cancer Consumption Value Market Share by Type (2019-2030)
    Figure 51. Asia-Pacific Personalized Medicine for Cancer Consumption Value Market Share by Application (2019-2030)
    Figure 52. Asia-Pacific Personalized Medicine for Cancer Consumption Value Market Share by Region (2019-2030)
    Figure 53. China Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 54. Japan Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 55. South Korea Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 56. India Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 57. Southeast Asia Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 58. Australia Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 59. South America Personalized Medicine for Cancer Consumption Value Market Share by Type (2019-2030)
    Figure 60. South America Personalized Medicine for Cancer Consumption Value Market Share by Application (2019-2030)
    Figure 61. South America Personalized Medicine for Cancer Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 63. Argentina Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 64. Middle East and Africa Personalized Medicine for Cancer Consumption Value Market Share by Type (2019-2030)
    Figure 65. Middle East and Africa Personalized Medicine for Cancer Consumption Value Market Share by Application (2019-2030)
    Figure 66. Middle East and Africa Personalized Medicine for Cancer Consumption Value Market Share by Country (2019-2030)
    Figure 67. Turkey Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 68. Saudi Arabia Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 69. UAE Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 70. Personalized Medicine for Cancer Market Drivers
    Figure 71. Personalized Medicine for Cancer Market Restraints
    Figure 72. Personalized Medicine for Cancer Market Trends
    Figure 73. Porters Five Forces Analysis
    Figure 74. Manufacturing Cost Structure Analysis of Personalized Medicine for Cancer in 2023
    Figure 75. Manufacturing Process Analysis of Personalized Medicine for Cancer
    Figure 76. Personalized Medicine for Cancer Industrial Chain
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Companies Mentioned

Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Ariad Pharmaceuticals (Takeda)
Eli Lilly
Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals